Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration's adverse event reporting system databases

• Principais autores: Qiaofang Liang (Autor), Xiaolin Liao (Autor), Hongwen Wu (Autor), Yushen Huang (Autor), Taolin Liang (Autor), Hailong Li (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

BackgroundThis study aimed to investigate the real-world profile of adverse events (AEs) associated with gepant medications in the clinical treatment of migraines by analyzing data collected from the VigiAccess database and the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (...